- Ongoing, recruitingTherapeutic exploratory (Phase II)
FLUOPANC II: A performance study of SGM-101, a fluorochrome-labeled anti-carcinoembryonic antigen monoclonal antibody for fluorescence-guided imaging to determine local extent and resectability during surgical resection of pancreatic ductal adenocarcinoma after neoadjuvant treatment.
This study looks at a special dye called SGM-101 to help surgeons see pancreatic cancer more clearly during an operation. It aims to improve how doctors find and remove all the cancer, especially after other treatments have been given.
For: Pancreatic tumorNetherlands - Ongoing, recruitingTherapeutic exploratory (Phase II)
Focus Green: Fluorescence-guided resection Of Colorectal liver metastases Using SGM-101 and Indocyanine GREEN
This study looks at new ways to find and remove bowel cancer that has spread to the liver. It uses special dyes and imaging during surgery to help surgeons see cancer cells more clearly and make sure all of them are removed, improving treatment.
For: colorectal livermetastasesNetherlands - RecruitingPHASE3
Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer
This study is testing a new way to help surgeons see bowel cancer more clearly during operations. It compares a special dye, SGM-101, with standard viewing methods to find cancer cells in and around the bowel.
For: Colorectal NeoplasmsUnited States · Germany · Italy